{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:40:33Z","timestamp":1793018433745,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872362"],"award-info":[{"award-number":["81872362"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072665"],"award-info":[{"award-number":["82072665"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021LZL001"],"award-info":[{"award-number":["ZR2021LZL001"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Breast cancer (BC) is the most common malignant tumor in women worldwide. Metastasis is the main cause of BC-related death. The specific mechanism underlying BC metastasis remains obscure. Recently, PRSS22 was discovered to be involved in tumor development, however, its detailed biological function and regulatory mechanism in BC are unclear. Here, we characterized that PRSS22 expression is upregulated in BC tissues compared with non-tumorous breast tissues. Dual luciferase assays, bioinformatics analyses and chromatin immunoprecipitation (ChIP) assays indicated that transcription factor E2F1 directly binds to the PRSS22 promoter region and activates its transcription. Functionally, upregulation of PRSS22 promoted invasion and metastasis of BC cells in vitro and in vivo, whereas knockdown of PRSS22 inhibited its function. Mechanistically, the combination of PRSS22 and ANXA1 protein in BC cells was first screened by protein mass spectrometry analysis, and then confirmed by co-immunoprecipitation (Co-IP) and western blot assays. Co-overexpression of PRSS22 and ANXA1 could promote BC cell migration and invasion. We further demonstrated that PRSS22 promotes the cleavage of ANXA1 and in turn generates an N-terminal peptide, which initiates the FPR2\/ERK signaling axis to increase BC aggressiveness.<\/jats:p>","DOI":"10.1038\/s41419-022-05414-3","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T20:10:44Z","timestamp":1669147844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["E2F1-initiated transcription of PRSS22 promotes breast cancer metastasis by cleaving ANXA1 and activating FPR2\/ERK signaling pathway"],"prefix":"10.1038","volume":"13","author":[{"given":"Lin","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran-Ran","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Nan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5137-449X","authenticated-orcid":false,"given":"Xiao-Juan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6596-6728","authenticated-orcid":false,"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4721-0887","authenticated-orcid":false,"given":"Peng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"key":"5414_CR1","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","volume":"39710286","author":"S Loibl","year":"2021","unstructured":"Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G. Breast cancer. Lancet. 2021;39710286:1750\u201369.","journal-title":"Lancet."},{"key":"5414_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcancer.2019.08.012","volume":"60","author":"Y Liang","year":"2020","unstructured":"Liang Y, Zhang H, Song X, Yang Q. Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Semin Cancer Biol. 2020;60:14\u201327.","journal-title":"Semin Cancer Biol"},{"key":"5414_CR3","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1038\/onc.2017.163","volume":"3640","author":"H Zhang","year":"2017","unstructured":"Zhang H, Ma RR, Wang XJ, Su ZX, Chen X, Shi DB, et al. KIF26B, a novel oncogene, promotes proliferation and metastasis by activating the VEGF pathway in gastric cancer. Oncogene. 2017;3640:5609\u201319.","journal-title":"Oncogene."},{"key":"5414_CR4","doi-asserted-by":"publisher","first-page":"49169","DOI":"10.1074\/jbc.M108677200","volume":"27652","author":"GW Wong","year":"2001","unstructured":"Wong GW, Yasuda S, Madhusudhan MS, Li L, Yang Y, Krilis SA, et al. Human tryptase epsilon (PRSS22), a new member of the chromosome 16p13.3 family of human serine proteases expressed in airway epithelial cells. J Biol Chem. 2001;27652:49169\u201382.","journal-title":"J Biol Chem"},{"key":"5414_CR5","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1182\/blood-2003-10-3501","volume":"10510","author":"S Yasuda","year":"2005","unstructured":"Yasuda S, Morokawa N, Wong GW, Rossi A, Madhusudhan MS, Sali A, et al. Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase epsilon\/PRSS22. Blood. 2005;10510:3893\u2013901.","journal-title":"Blood."},{"key":"5414_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-162","volume":"13","author":"CY Chen","year":"2014","unstructured":"Chen CY, Chung IH, Tsai MM, Tseng YH, Chi HC, Tsai CY, et al. Thyroid hormone enhanced human hepatoma cell motility involves brain-specific serine protease 4 activation via ERK signaling. Mol Cancer. 2014;13:162.","journal-title":"Mol Cancer"},{"key":"5414_CR7","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/his.12662","volume":"673","author":"E Specht","year":"2015","unstructured":"Specht E, Kaemmerer D, Sanger J, Wirtz RM, Schulz S, Lupp A. Comparison of immunoreactive score, HER2\/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms. Histopathology. 2015;673:368\u201377.","journal-title":"Histopathology."},{"key":"5414_CR8","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.jhep.2010.09.023","volume":"546","author":"P Gao","year":"2011","unstructured":"Gao P, Wong CC, Tung EK, Lee JM, Wong CM, Ng IO. Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis. J Hepatol. 2011;546:1177\u201384.","journal-title":"J Hepatol"},{"key":"5414_CR9","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.1158\/0008-5472.CAN-18-1011","volume":"7820","author":"HT Liu","year":"2018","unstructured":"Liu HT, Liu S, Liu L, Ma RR, Gao P. EGR1-mediated transcription of lncRNA-HNF1A-AS1 promotes cell-cycle progression in gastric cancer. Cancer Res. 2018;7820:5877\u201390.","journal-title":"Cancer Res"},{"key":"5414_CR10","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1158\/0008-5472.CAN-21-1179","volume":"825","author":"W Zhu","year":"2022","unstructured":"Zhu W, Chen X, Guo X, Liu H, Ma R, Wang Y, et al. Low glucose-induced overexpression of HOXC-AS3 promotes metabolic reprogramming of breast cancer. Cancer Res. 2022;825:805\u201318.","journal-title":"Cancer Res"},{"key":"5414_CR11","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1002\/1878-0261.12778","volume":"1410","author":"BB Lv","year":"2020","unstructured":"Lv BB, Ma RR, Chen X, Zhang GH, Song L, Wang SX, et al. E2F1-activated SPIN1 promotes tumor growth via a MDM2-p21-E2F1 feedback loop in gastric cancer. Mol Oncol. 2020;1410:2629\u201345.","journal-title":"Mol Oncol"},{"key":"5414_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/path.4743","volume":"2394","author":"X Chen","year":"2016","unstructured":"Chen X, Wang YW, Xing AY, Xiang S, Shi DB, Liu L, et al. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer. J Pathol. 2016;2394:459\u201372.","journal-title":"J Pathol"},{"key":"5414_CR13","doi-asserted-by":"publisher","first-page":"e111317","DOI":"10.1371\/journal.pone.0111317","volume":"912","author":"TS Gastardelo","year":"2014","unstructured":"Gastardelo TS, Cunha BR, Raposo LS, Maniglia JV, Cury PM, Lisoni FC, et al. Inflammation and cancer: role of annexin A1 and FPR2\/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma. PLoS ONE. 2014;912:e111317.","journal-title":"PLoS ONE"},{"key":"5414_CR14","doi-asserted-by":"publisher","first-page":"29998","DOI":"10.1074\/jbc.M702876200","volume":"28241","author":"L Vong","year":"2007","unstructured":"Vong L, D\u2019Acquisto F, Pederzoli-Ribeil M, Lavagno L, Flower RJ, Witko-Sarsat V, et al. Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3. J Biol Chem. 2007;28241:29998\u201330004.","journal-title":"J Biol Chem"},{"key":"5414_CR15","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.bbamcr.2006.08.041","volume":"176311","author":"U Rescher","year":"2006","unstructured":"Rescher U, Goebeler V, Wilbers A, Gerke V. Proteolytic cleavage of annexin 1 by human leukocyte elastase. Biochim Biophys Acta. 2006;176311:1320\u20134.","journal-title":"Biochim Biophys Acta"},{"key":"5414_CR16","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S1097-2765(00)80323-8","volume":"55","author":"A Walther","year":"2000","unstructured":"Walther A, Riehemann K, Gerke V. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol Cell. 2000;55:831\u201340.","journal-title":"Mol Cell"},{"key":"5414_CR17","doi-asserted-by":"publisher","first-page":"7669","DOI":"10.4049\/jimmunol.172.12.7669","volume":"17212","author":"S Ernst","year":"2004","unstructured":"Ernst S, Lange C, Wilbers A, Goebeler V, Gerke V, Rescher U. An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family. J Immunol. 2004;17212:7669\u201376.","journal-title":"J Immunol"},{"key":"5414_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2006.01.034","volume":"5341-3","author":"R Selvatici","year":"2006","unstructured":"Selvatici R, Falzarano S, Mollica A, Spisani S. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur J Pharm. 2006;5341-3:1\u201311.","journal-title":"Eur J Pharm"},{"key":"5414_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00314-5","volume":"71","author":"L Zhang","year":"2017","unstructured":"Zhang L, Wang G, Chen X, Xue X, Guo Q, Liu M, et al. Formyl peptide receptors promotes neural differentiation in mouse neural stem cells by ROS generation and regulation of PI3K-AKT signaling. Sci Rep. 2017;71:206.","journal-title":"Sci Rep"},{"key":"5414_CR20","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1111\/j.1742-4658.2005.04901.x","volume":"27219","author":"S Mitsui","year":"2005","unstructured":"Mitsui S, Okui A, Kominami K, Konishi E, Uemura H, Yamaguchi N. A novel serine protease highly expressed in the pancreas is expressed in various kinds of cancer cells. FEBS J. 2005;27219:4911\u201323.","journal-title":"FEBS J"},{"key":"5414_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2007.11.031","volume":"131","author":"TC Hallstrom","year":"2008","unstructured":"Hallstrom TC, Mori SNevins JR. An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell. 2008;131:11\u201322.","journal-title":"Cancer Cell"},{"key":"5414_CR22","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/ncb868","volume":"411","author":"Z Nahle","year":"2002","unstructured":"Nahle Z, Polakoff J, Davuluri RV, McCurrach ME, Jacobson MD, Narita M, et al. Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol. 2002;411:859\u201364.","journal-title":"Nat Cell Biol"},{"key":"5414_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2021.05.012","volume":"514","author":"D Shen","year":"2021","unstructured":"Shen D, Gao Y, Huang Q, Xuan Y, Yao Y, Gu L, et al. E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis. Cancer Lett. 2021;514:48\u201362.","journal-title":"Cancer Lett"},{"key":"5414_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03797-3","volume":"126","author":"J Ma","year":"2021","unstructured":"Ma J, He Z, Zhang H, Zhang W, Gao S, Ni X. SEC61G promotes breast cancer development and metastasis via modulating glycolysis and is transcriptionally regulated by E2F1. Cell Death Dis. 2021;126:550.","journal-title":"Cell Death Dis"},{"key":"5414_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-4-95","volume":"4","author":"RM Hallett","year":"2011","unstructured":"Hallett RM, Hassell JA. E2F1 and KIAA0191 expression predicts breast cancer patient survival. BMC Res Notes. 2011;4:95.","journal-title":"BMC Res Notes"},{"key":"5414_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47218-0","volume":"91","author":"DP Hollern","year":"2019","unstructured":"Hollern DP, Swiatnicki MR, Rennhack JP, Misek SA, Matson BC, McAuliff A, et al. E2F1 drives breast cancer metastasis by regulating the target gene FGF13 and altering cell migration. Sci Rep. 2019;91:10718.","journal-title":"Sci Rep"},{"key":"5414_CR27","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1096\/fj.06-7464rev","volume":"214","author":"LH Lim","year":"2007","unstructured":"Lim LH, Pervaiz S. Annexin 1: the new face of an old molecule. FASEB J. 2007;214:968\u201375.","journal-title":"FASEB J"},{"key":"5414_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1165\/ajrcmb.18.1.2808","volume":"181","author":"FH Tsao","year":"1998","unstructured":"Tsao FH, Meyer KC, Chen X, Rosenthal NS, Hu J. Degradation of annexin I in bronchoalveolar lavage fluid from patients with cystic fibrosis. Am J Respir Cell Mol Biol. 1998;181:120\u20138.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"5414_CR29","doi-asserted-by":"publisher","first-page":"e45639","DOI":"10.1371\/journal.pone.0045639","volume":"79","author":"V Bizzarro","year":"2012","unstructured":"Bizzarro V, Fontanella B, Carratu A, Belvedere R, Marfella R, Parente L, et al. Annexin A1 N-terminal derived peptide Ac2-26 stimulates fibroblast migration in high glucose conditions. PLoS ONE. 2012;79:e45639.","journal-title":"PLoS ONE"},{"key":"5414_CR30","doi-asserted-by":"publisher","first-page":"19588","DOI":"10.1074\/jbc.M513025200","volume":"28128","author":"BA Babbin","year":"2006","unstructured":"Babbin BA, Lee WY, Parkos CA, Winfree LM, Akyildiz A, Perretti M, et al. Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem. 2006;28128:19588\u201399.","journal-title":"J Biol Chem"},{"key":"5414_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0392-6","volume":"13","author":"M Sobral-Leite","year":"2015","unstructured":"Sobral-Leite M, Wesseling J, Smit VT, Nevanlinna H, van Miltenburg MH, Sanders J, et al. Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis. BMC Med. 2015;13:156.","journal-title":"BMC Med"},{"key":"5414_CR32","doi-asserted-by":"publisher","first-page":"6340","DOI":"10.1073\/pnas.0913360107","volume":"10714","author":"M de Graauw","year":"2010","unstructured":"de Graauw M, van Miltenburg MH, Schmidt MK, Pont C, Lalai R, Kartopawiro J, et al. Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci USA. 2010;10714:6340\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5414_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-60761-795-2_1","volume":"661","author":"Y Keshet","year":"2010","unstructured":"Keshet Y, Seger R. The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions. Methods Mol Biol. 2010;661:3\u201338.","journal-title":"Methods Mol Biol"},{"key":"5414_CR34","first-page":"1997","volume":"193","author":"YJ Guo","year":"2020","unstructured":"Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y, Hu LL. ERK\/MAPK signalling pathway and tumorigenesis. Exp Ther Med. 2020;193:1997\u20132007.","journal-title":"Exp Ther Med"},{"key":"5414_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1042\/bj3510289","volume":"351","author":"W Kolch","year":"2000","unstructured":"Kolch W. Meaningful relationships: the regulation of the Ras\/Raf\/MEK\/ERK pathway by protein interactions. Biochem J 2000;351:289\u2013305.","journal-title":"Biochem J"},{"key":"5414_CR36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/1097-0215(20010720)95:4<247::AID-IJC1042>3.0.CO;2-S","volume":"954","author":"JM Gee","year":"2001","unstructured":"Gee JM, Robertson JF, Ellis IO, Nicholson RI. Phosphorylation of ERK1\/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer. Int J Cancer. 2001;954:247\u201354.","journal-title":"Int J Cancer"},{"key":"5414_CR37","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1038\/sj.onc.1204383","volume":"2019","author":"E Shaulian","year":"2001","unstructured":"Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene. 2001;2019:2390\u2013400.","journal-title":"Oncogene."},{"key":"5414_CR38","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1093\/emboj\/19.9.2056","volume":"199","author":"L Bakiri","year":"2000","unstructured":"Bakiri L, Lallemand D, Bossy-Wetzel E, Yaniv M. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J. 2000;199:2056\u201368.","journal-title":"EMBO J"},{"key":"5414_CR39","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1073\/pnas.96.4.1433","volume":"964","author":"F Beier","year":"1999","unstructured":"Beier F, Lee RJ, Taylor AC, Pestell RG, LuValle P. Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes. Proc Natl Acad Sci USA. 1999;964:1433\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5414_CR40","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1128\/MCB.18.9.5609","volume":"189","author":"JR Brown","year":"1998","unstructured":"Brown JR, Nigh E, Lee RJ, Ye H, Thompson MA, Saudou F, et al. Fos family members induce cell cycle entry by activating cyclin D1. Mol Cell Biol. 1998;189:5609\u201319.","journal-title":"Mol Cell Biol"},{"key":"5414_CR41","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/emboj\/18.1.188","volume":"181","author":"R Wisdom","year":"1999","unstructured":"Wisdom R, Johnson RS, Moore C. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 1999;181:188\u201397.","journal-title":"EMBO J"},{"key":"5414_CR42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0378-1119(02)01055-7","volume":"2991-2","author":"O Coqueret","year":"2002","unstructured":"Coqueret O. Linking cyclins to transcriptional control. Gene. 2002;2991-2:35\u201355.","journal-title":"Gene."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05414-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05414-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05414-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T20:10:48Z","timestamp":1669147848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05414-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["5414"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05414-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1778553\/v1","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,21]]},"assertion":[{"value":"20 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Clinical tissue samples were obtained from Qilu Hospital of Shandong University. This study was approved by the Research Ethics Committee of Shandong University of Medicine and is in accordance with the ethical guidelines of the World Medical Association Declaration of Helsinki. All of the animal experiments were conducted according to the Guidelines for Animal Health and Use (Ministry of Science and Technology, China, 2006). Animal experiments were approved by the Committee on the Ethics of Animal Experiments of Basic Medical Sciences, Shandong University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"982"}}